XML 51 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Operating Expenses:        
Research and development $ 608,019 $ 504,787 $ 1,945,043 $ 1,008,127
General and administration expenses 527,829 245,773 1,486,386 546,621
Total Operating Expenses 1,135,848 750,560 3,431,429 1,554,748
Loss From Operations (1,135,848) (750,560) (3,431,429) (1,554,748)
Other Income (Expenses):        
Interest income 2,331 11,355 28,148 22,203
Net Loss $ (1,133,517) $ (739,205) $ (3,403,281) $ (1,532,545)
Net Loss Per Share:        
Basic and Diluted $ (0.06) $ (0.04) $ (0.19) $ (0.09)
Weighted average number of shares used in computing basic and diluted net loss per share:        
Basic and Diluted 17,870,261 16,848,236 17,862,625 16,272,642